Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
| Metric | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | -0 | 0 | 0 |
| Operating Income | -3 | -8 | -11 |
| Net Income | -7 | -8 | -11 |
| EBITDA | -7 | -8 | -11 |
| EPS Diluted | -8.66 | -9.63 | -8.73 |
| Metric | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|
| Cash & Equivalents | 0 | 8 | 10 |
| Total Current Assets | 1 | 8 | 10 |
| Total Assets | 1 | 9 | 10 |
| Total Current Liabilities | 1 | 1 | 3 |
| Total Liabilities | 6 | 1 | 3 |
| Total Equity | -6 | 8 | 7 |
| Total Debt | 1 | 0 | 0 |
| Net Debt | 1 | -8 | -10 |
| Metric | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|
| Operating Cash Flow | -1 | -4 | -7 |
| Capital Expenditure | 0 | -0 | -0 |
| Free Cash Flow | -1 | -4 | -7 |
| Stock-Based Comp | 0 | 1 | 1 |
| Net Change in Cash | 0 | 8 | 2 |